LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Sight Sciences (NASDAQ: SGHT)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SGHT Sight Sciences
Badawi David / director, officer: Chief Technology Officer
07/17/2025
Buy
$0.12
40,000
$5K
1.87M
NASDAQ SGHT Sight Sciences
Badawi David / director, officer: Chief Technology Officer
07/17/2025
Sell
$0.12
40,000
$5K
0
NASDAQ SGHT Sight Sciences
HAYDEN JEREMY B. / officer: Chief Legal Officer
07/03/2025
Sell
$4.17
9,160
$38K
266,321
NASDAQ SGHT Sight Sciences
Bauerlein Alison / officer: Chief Financial Officer
07/02/2025
Sell
$4.10
19,260
$79K
617,468
NASDAQ SGHT Sight Sciences
Badawi Paul / director, officer: President and CEO
07/01/2025
Sell
$4.15
23,637
$98K
5.99M
NASDAQ SGHT Sight Sciences
Badawi David / director, officer: Chief Technology Officer
07/03/2025
Sell
$4.17
5,679
$24K
1.83M
NASDAQ SGHT Sight Sciences
Link Matthew / officer: Chief Commercial Officer
07/02/2025
Sell
$4.10
4,889
$20K
832,293
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
06/06/2025
Buy
$4.22
27,900
$118K
1.38M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
06/05/2025
Buy
$4.24
40,951
$174K
1.32M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
06/04/2025
Buy
$4.17
21,674
$90K
1.28M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
06/03/2025
Buy
$3.97
25,230
$100K
1.26M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
06/02/2025
Buy
$3.88
30,799
$119K
1.23M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
05/30/2025
Buy
$3.67
42,753
$157K
1.20M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
05/29/2025
Buy
$3.59
60,128
$216K
1.16M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
05/28/2025
Buy
$3.52
26,715
$94K
1.10M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
05/27/2025
Buy
$3.44
41,346
$142K
1.07M